Loading...
Learning from the past for TB drug discovery in the future
Tuberculosis drug discovery has shifted in recent years from a primarily target-based approach to one that uses phenotypic high-throughput screens. As examples of this, through our EU-funded FP7 collaborations, New Medicines for Tuberculosis was target-based and our more-recent More Medicines for Tu...
Na minha lista:
| Udgivet i: | Drug Discov Today |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5362327/ https://ncbi.nlm.nih.gov/pubmed/27717850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2016.09.025 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|